Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SWI5-dependent HO expression protein 3 (She3) is a critical adapter protein involved in the asymmetric distribution of genetic material and organelles in budding yeast and pathogenic fungi. It functions by bridging the RNA-binding protein She2p and its associated mRNA cargo (such as ASH1 mRNA) to the Myo4p myosin V motor, allowing the motor to pull the complex along actin cables toward the emerging bud. Beyond its role in simple yeast budding, She3 is particularly important in the human pathogen Candida albicans, where it is required for hyphal growth and the transport of virulence-related factors to the hyphal tip. Because the yeast-to-hypha transition is a major driver of host tissue invasion and systemic infection, She3 represents an attractive target for antifungal drug development. Currently, research into She3 focuses on its potential as a virulence factor target, although no clinical inhibitors have been identified to date.
Acts as a molecular adapter that links the She2p-mRNA complex to the Myo4p myosin V motor, enabling the active transport of messenger RNAs and cortical endoplasmic reticulum along actin filaments toward the cell bud or hyphal tip.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SWI5-dependent HO expression protein 3 (She3).